Earnings · China A-shares
Tasly Pharmaceutical Group Co. Ltd. Class A (600535) earnings
Tasly Pharmaceutical Group Co. Ltd. Class A published its Q3 report on 2026-10-23: net profit +12.01% year on year, +34.96% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -0.73% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-23
- Period end
- 2026-09-30
- Net profit YoY
- +12.01%
- Excl. one-offs YoY
- +34.96%
- Net profit QoQ
- -59.83%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.23% | — |
| 3 days | -0.73% | — |
| 7 days | +4.72% | — |
| 14 days | +1.31% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 3 of 8 reports (average +0.79%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-24 | ¥1.10B | +12.01% | +34.96% | -3.76% | 0.74 | 8.58% | -0.73% | — | — |
| 2026 interim report | 2026-08-22 | ¥892.68M | +15.23% | +36.00% | -2.03% | 0.60 | 6.98% | -1.34% | -5.01% | +1.90% |
| 2026 Q1 report | 2026-04-25 | ¥370.24M | +17.80% | +54.23% | +5.35% | 0.25 | 2.94% | +3.90% | -1.98% | -1.68% |
| 2025 annual report | 2026-03-20 | ¥1.10B | +15.63% | -23.59% | -3.08% | 0.74 | 9.09% | -3.33% | +7.23% | +0.85% |
| 2025 Q3 report | 2025-10-25 | ¥984.37M | +16.88% | -15.59% | -2.35% | 0.66 | 8.06% | -1.91% | -2.35% | -2.13% |
| 2025 interim report | 2025-08-16 | ¥774.70M | +16.97% | -12.87% | -1.91% | 0.52 | 6.38% | +7.60% | -2.90% | -11.21% |
| 2025 Q1 report | 2025-04-29 | ¥314.31M | +6.47% | -19.54% | +0.30% | 0.21 | 2.61% | +3.17% | +8.02% | +5.44% |
| 2024 annual report | 2025-02-25 | ¥955.59M | -10.78% | -12.31% | -2.03% | 0.64 | 7.68% | -1.06% | -2.32% | +7.26% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.